| Sub-title | |
| Authors | M Zarb Adami A Serracino Inglott L M Azzopardi A Spiteri |
| Abstract | Introduction: Continuous ambulatory peritoneal dialysis (CAPD) supports patients with renal disease to keep following their daily activities as much as possible. Aims: To calculate yearly costs per CAPD patient and per haemodialysis patient, and to identify the impact of treatment on the patients quality of life. Method: The yearly hospital costs per CAPD patient and per heamodialysis patient were calculated. The McGill Quality of Life instrument was administered to 50 CAPD patients and to 50 haemodialyis patients (average age 58 years). The total yearly cost per CAPD patient (catheter insertion, teaching sessions, accessories, monitoring costs, antibiotic and epoetin treatment), total yearly cost per haemodialysis patient (fistular insertion, accessories, monitoring costs, equipment, treatment sessions, epoetin treatment), were calculated. Results: The annual dialysis costs: 16 730 Euro per CAPD patient, 36 761 Euro per haemodialysis patient. From the McGill Quality of Life instrument, the average score obtained out of 190 was: 150 by CAPD patients, 151 by haemodialysis patients. Restlessness was the most common symptom experienced by both CAPD (30%) and haemodialysis (50%) patients followed by pain due to peritonitis for CAPD patients (24%) and insomnia for haemodialysis patients (22%). Conclusion: The annual expense to maintain a patient on haemodialysis is about two times more than to maintain a patient on CAPD. Although restlessness was more common in haemodialysis patients, there was no significant difference in the quality of life of CAPD and of haemodialysis patients. |
Published in: | |
| Journal | Malta Medical Journal |
| Volume | 15 Issue 1-2/suppl. 2003 |
| Page | |
| Date | |
| Link to journal | |
| Key words | continuous ambulatory peritoneal dialysis, pharmacy, quality of life, pharmacoeconomics |